Plasma Peptide Biomarker Discovery for Amyotrophic Lateral Sclerosis by MALDI –TOF Mass Spectrometry Profiling

The diagnostic of Amyotrophic lateral sclerosis (ALS) remains based on clinical and neurophysiological observations. The actual delay between the onset of the symptoms and diagnosis is about 1 year, preventing early inclusion of patients into clinical trials and early care of the disease. Therefore,...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Conraux, Laurence, Pech, Catherine, Guerraoui, Halim, Loyaux, Denis, Ferrara, Pascual, Guillemot, Jean-Claude, Meininger, Vincent, Pradat, Pierre-François, Salachas, François, Bruneteau, Gaëlle, Le Forestier, Nadine, Lacomblez, Lucette
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2013
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3818176/
https://ncbi.nlm.nih.gov/pubmed/24224000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0079733
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia